EPA must review glyphosate again – Bayer wins further lawsuit

Bayer

The weed killer is still a legal risk for Bayer.

(Photo: dpa)

San Francisco The US Environmental Protection Agency has been ordered by an appeals court to re-examine the health risks of glyphosate. On Friday (local time) in San Francisco, the court classified the EPA’s assessment, according to which the active ingredient in Bayer’s controversial weed killer Roundup poses no particular danger to humans, as doubtful.

The topic is of great importance for the German Bayer group. He is facing numerous US lawsuits in the US over alleged cancer risks from glyphosate. On Friday there was also good news for the Dax company: In a case in the state of Oregon, it achieved another success in court. Bayer has now won the last four US lawsuits involving plaintiffs who blame glyphosate for cancer.

The EPA last reviewed the weed killer in 2020 and maintained that it posed no health risk when used correctly. The environmental organization NRDC, among others, complained about this. “For years, the EPA has refused to do anything about the harmful effects of this pesticide on humans and the environment,” the organization said on Friday. The court made it clear that things could not go on like this.

In its ruling, the responsible court of appeals was particularly bothered by the way the EPA justified that glyphosate is not carcinogenic. The underlying analysis is “flawed” and partially inconsistent with the agency’s guidelines. The EPA declined to comment on the criticism when asked. A spokeswoman said the glyphosate decision would be reviewed.

Tagus Top-Jobs

Find the best jobs now and
be notified by email.

Three cases lost in the US

In a statement, Bayer expressed confidence that the EPA found no cancer risks from glyphosate even in a new review. The U.S. government environmental agency acted conscientiously last time, conducting a “rigorous” evaluation of scientific studies from the past 40 years. Bayer had shouldered the glyphosate lawsuits with its $60 billion acquisition of seed giant Monsanto in 2018.

The many procedures in the USA are based in particular on an assessment by the International Agency for Research on Cancer of the World Health Organization. In 2015, she classified Monsanto’s weed killer as “probably carcinogenic” to humans. Bayer denies this, arguing with the approval of many regulatory agencies and studies that are intended to show that glyphosate is safe when used as directed.

The tide finally turned after Bayer lost the first three glyphosate lawsuits in the United States. On Friday, the Dax group won the fourth procedure in a row. The Jackson County, Oregon grand jury unanimously found Roundup not responsible for plaintiff’s cancer. “We remain fully behind Roundup’s security,” Bayer said. The group announced that it would “self-confidently” defend itself in all future legal conflicts on the subject.

More: Bayer’s hope for a quick end to the glyphosate process is fading.

Facebook
Twitter
LinkedIn
Pinterest
Pocket
WhatsApp

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Recent News

Editor's Pick